CStone Pharmaceuticals (HK:2616) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CStone Pharmaceuticals has announced a board meeting scheduled for August 23, 2024, to discuss and approve its unaudited interim financial results for the first half of the year and to consider declaring an interim dividend. The meeting will be an important event for the company and its subsidiaries as they evaluate their mid-year financial performance.
For further insights into HK:2616 stock, check out TipRanks’ Stock Analysis page.